MAKE AN APPOINTMENT
One Hatfield 01707 443333
Spire Bushey 0208 950 9090
Spire Cambridge Lea 01223 266900
Harley Street 020 7079 2100
Alternatively call Elaine Coles (Secretary) - 07375 064324 / info@hertskidneycare.co.uk
MAKE AN APPOINTMENT
One Hatfield 01707 443333
Spire Bushey 0208 950 9090
Spire Cambridge Lea 01223 266900
Harley Street 020 7079 2100
Alternatively call Elaine Coles (Secretary) - 07375 064324 / info@hertskidneycare.co.uk
A New Era in Post-Transplant Monitoring : Advances in molecular diagnostics are ready to improve the approach to care and enhance patients’ quality of life. Rumpler MJ, McCloskey CC, Lawrence C. Clinical Laboratory News. American Association for Clinical Chemistry (AACC). April2023. A New Era in Post-Transplant Monitoring | AACC.org
Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study Transplantation. Halloran PF, Reeve J, Madill-Thomsen KS, Demko Z, Prewett A, Gauthier P, Billings P, Lawrence C, Lowe D, Hidalgo LG; the Trifecta Investigators 2023 Mar 1;107(3):709-719. doi: 10.1097/TP.0000000000004324. Epub 2023 Feb 21.
Response to Commentary on development of the "molecular microscope (MMDx) assay for heart transplant rejection surveillance: SCVP journal club". Manion H, McCloskey C, Ramesh P, Lawrence C. Cardiovasc Pathol. 2023 Mar-Apr; 63:107486. doi: 10.1016/j.carpath.2022.107486. Epub 2022 Oct 3.
The Molecular Microscope Diagnostic System (MMDx) interpretation of solid organ allograft biopsies: Restoring the perspective. McCloskey C,Zubrycki M, Lawrence C. Clin Transplant. 2022 Aug;36(8):e14711. doi:10.1111/ctr.14711. Epub 2022 Jun 6.
US payer budget impact of a microarray assay with machine learning to evaluate kidney transplant rejection in for-cause biopsies. Fusfeld L, MenonS, Gupta G, Lawrence C, Masud SF, Goss TF. J Med Econ. 2022 Jan-Dec;25(1):515-523. doi: 10.1080/13696998.2022.2059221.
Alternative cause for hypoglycaemia in insulin-treated diabetes mellitus. Parmar V, Sritharan V, Lawrence C, Dhere A. BMJ Case Rep. 2021Jul 23;14(7):e241439. doi: 10.1136/bcr-2020-241439.
Transplant programs during COVID-19: Unintended consequences for health inequality. Sharma S, Lawrence C, Giovinazzo F. Am J Transplant.2020 Jul;20(7):1954-1955. doi: 10.1111/ajt.15931. Epub 2020 May 10. PMID:32314551.
Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial. Medjeral-Thomas NR, Lawrence C, Condon M,Sood B, Warwicker P, Brown H, Pattison J, Bhandari S, Barratt J, Turner N, CookHT, Levy JB, Lightstone L, Pusey C, Galliford J, Cairns TD, Griffith M. Clin JAm Soc Nephrol. 2020 Feb 7;15(2):209-218. doi: 10.2215/CJN.06180519. Epub 2020 Jan 17. Erratum in: Clin J Am Soc Nephrol. 2020 Jul 1;15(7):1027. PMID:31953303; PMCID: PMC7015084.
A Complicated Pregnancy in an Adult with HNF4A p.R63W-Associated Fanconi Syndrome. Anyiam O, Wallin E, Kaplan F, Lawrence C. Case RepMed. 2019 Dec 25;2019:2349470. doi: 10.1155/2019/2349470. eCollection 2019.
1: Hucker A, Bunn F, Carpenter L, Lawrence C, Farrington K, Sharma S.Non-adherence to immunosuppressants following renal transplantation: a protocolfor a systematic review. BMJ Open. 2017 Sep 28;7(9):e015411. doi:10.1136/bmjopen-2016-015411. PubMed PMID: 28963283; PubMed Central PMCID:PMC5640118.
2: Lawrence C, Sharma S, Da Silva-Gane M, Fletcher BC, Farrington K. Exploringthe views of patients not on the transplant waiting list: a qualitative study. J Ren Care. 2013 Jun;39(2):118-24. doi: 10.1111/j.1755-6686.2013.12012.x. PubMedPMID: 23683305.
3: Jolly EC, Clatworthy MR, Lawrence C, Nathan PD, Farrington K. Anti-CTLA-4 (CD 152) monoclonal antibody-induced autoimmune interstitial nephritis. NDT Plus.2009 Aug;2(4):300-2. doi: 10.1093/ndtplus/sfp048. Epub 2009 Apr 28. PubMed PMID: 25984021; PubMed Central PMCID: PMC4421243.
4: Borrows R, Chan K, Loucaidou M, Lawrence C, Van Tromp J, Cairns T, Griffith M,Hakim N, McLean A, Palmer A, Papalois V, Taube D. Five years of steroid sparingin renal transplantation with tacrolimus and mycophenolate mofetil.Transplantation. 2006 Jan 15;81(1):125-8. PubMed PMID: 16421488.
5: Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T,Roufosse C, Taube D, Warrens AN. Preformed complement-activating low-leveldonor-specific antibody predicts early antibody-mediated rejection in renalallografts. Transplantation. 2013 Jan 27;95(2):341-6. doi:10.1097/TP.0b013e3182743cfa. PubMed PMID: 23197178.
6: Lawrence C, Cook HT, Lightstone L. Seasonal relapsing minimal change disease: a novel strategy for avoiding long-term immunosuppression. Case Rep Nephrol Urol.2012 Jul;2(2):102-7. doi: 10.1159/000341257. Epub 2012 Jul 24. PubMed PMID:23197964; PubMed Central PMCID: PMC3482073.
7: Lawrence C, Galliford JW, Willicombe MK, McLean AG, Lesabe M, Rowan F,Papalois V, Regan F, Taube D. Antibody removal before ABO-incompatible renaltransplantation: how much plasma exchange is therapeutic? Transplantation. 2011Nov 27;92(10):1129-33. doi: 10.1097/TP.0b013e31823360cf. PubMed PMID: 21959216.
8: Lawrence C, Clarke C, Willicombe M. Complement-binding anti-HLA antibodies andkidney transplantation. N Engl J Med. 2014 Jan 2;370(1):84-5. doi:10.1056/NEJMc1313506. PubMed PMID: 24382078.
9: Dubrey SW, Rosser G, Shah KP, Lawrence C, Baburaj R, Mitchell C. Progressiveperiodic hypothermia and bradycardia. Br J Hosp Med (Lond). 2013 May;74(5):292-3.PubMed PMID: 23657028.
10: Stavrou BM, Lawrence C, Blackburn GM, Cohen T, Sheridan DJ, Flores NA.Coronary vasomotor and cardiac electrophysiologic effects of diadenosinepolyphosphates and nonhydrolyzable analogs in the guinea pig. J CardiovascPharmacol. 2001 May;37(5):571-84. PubMed PMID: 11336108.
11: Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K. Is there arationale for rationing chronic dialysis? A hospital based cohort study offactors affecting survival and morbidity. BMJ. 1999 Jan 23;318(7178):217-23.PubMed PMID: 9915728; PubMed Central PMCID: PMC27700.
